,58,79NPPA and NPPB, encoding atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), respectively, synthesized mostly in CMs, are clinically used as markers for the progression of HF, of which the biological cardioprotective property has been well studied, leading to drug development.81 This evidence concerns the gene NPPA and hydrops fetalis.